Literature DB >> 11999169

Positive and negative roles of CD72 in B cell function.

Hsin-Jung Wu1, Subbarao Bondada.   

Abstract

Regulation of B cell activation depends on integration of signals transmitted by the B cell receptor (BCR) and a variety of co-receptors. CD72 is a B cell co-receptor that is expressed in all stages of B cell development except plasma cells. Ligation of CD72 enhances B cell growth and differentiation. Recently, the class IV semaphoring, CD100, has been identified as the natural ligand for CD72. Cytoplasmic domain of CD72 has been shown to be associated with SHP-1 leading to the proposal that the positive effects of CD72 on B cell response may result from sequestration of negative signals from BCR. However, association of CD72 with Grb2 and/or CD19 suggests that CD72 could transmit positive signals. Based on these data, we propose a dual signaling model of CD72.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999169     DOI: 10.1385/IR:25:2:155

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  65 in total

1.  CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation.

Authors:  C Pan; N Baumgarth; J R Parnes
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

2.  Sequence of the Lyb-2 B-cell differentiation antigen defines a gene superfamily of receptors with inverted membrane orientation.

Authors:  E Nakayama; I von Hoegen; J R Parnes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Hyperresponsive B cells in CD22-deficient mice.

Authors:  T L O'Keefe; G T Williams; S L Davies; M S Neuberger
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

4.  CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.

Authors:  G Bikah; J Carey; J R Ciallella; A Tarakhovsky; S Bondada
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

5.  B cells in the bursa of Fabricius express a novel C-type lectin gene.

Authors:  R Goitsuka; C H Chen; M D Cooper
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

6.  Enhancement by monoclonal anti-Lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-Ficoll and T lymphocyte-derived factors.

Authors:  E C Snow; J J Mond; B Subbarao
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

7.  Early events in B-cell activation: anti-Lyb2, but not BSF-1, induces a phosphatidylinositol response in murine B cells.

Authors:  S A Grupp; J A Harmony; A R Baluyut; B Subbarao
Journal:  Cell Immunol       Date:  1987-11       Impact factor: 4.868

8.  Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.

Authors:  A Katira; M Kamal; J Gordon
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

9.  The motheaten mutation rescues B cell signaling and development in CD45-deficient mice.

Authors:  G Pani; K A Siminovitch; C J Paige
Journal:  J Exp Med       Date:  1997-08-18       Impact factor: 14.307

10.  Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes.

Authors:  L Biancone; M A Bowen; A Lim; A Aruffo; G Andres; I Stamenkovic
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  2 in total

1.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

2.  CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Authors:  Rafael Correa-Rocha; Jacobo Lopez-Abente; Carolina Gutierrez; Verónica Astrid Pérez-Fernández; Adrián Prieto-Sánchez; Santiago Moreno-Guillen; María-Ángeles Muñoz-Fernández; Marjorie Pion
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.